DURECT CORP (DRRX) has 72 open-market insider trades by 21 insiders since 2006. The most active filer is Felix Theeuwes, Chairman & CSO.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| First Eagle Value in Biotechnology Master Fund, Ltd. | 10% Owner | — | 3 | $11.8M | 2019-06-20 |
| 21 APRIL Fund, L.P. | 10% Owner | — | 1 | $5.8M | 2016-09-26 |
| Felix Theeuwes | ChairmanCSO | — | 15 | $3.0M | 2016-12-15 |
| 21 APRIL FUND L.P. | 10% Owner | — | 2 | $2.5M | 2016-01-11 |
| Bleichroeder LP | 10% Owner | — | 3 | $1.0M | 2023-03-13 |
| R. Scott Asen | 10% Owner | — | 2 | $786K | 2025-08-22 |
| Judy R. Joice | VP | — | 2 | $490K | 2021-05-14 |
| Judith J. Robertson | Dir | — | 4 | $282K | 2025-09-11 |
| Dave Hoffmann | Dir | — | 2 | $270K | 2017-09-21 |
| Gail J. Maderis | Dir | — | 2 | $190K | 2025-09-11 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| R. Scott Asen | 10% | Buy | $11K | 2025-08-22 |
| R. Scott Asen | 10% Owner | Buy | $774K | 2025-08-20 |
| Judith J. Robertson | Director | Buy | $130K | 2022-08-18 |
| Judith J. Robertson | Director | Buy | $9K | 2022-08-17 |
| Gail J. Maderis | Director | Buy | $18K | 2022-08-12 |
| Gail J. Maderis | Director | Buy | $172K | 2022-08-09 |
Companies that share insiders with DRRX, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| Judith J. Robertson | Director | Buy | $25K | 2022-05-26 |
| Mohammad Azab | Director | Buy | $8K | 2022-05-24 |
| Mohammad Azab | Director | Buy | $12K | 2022-05-16 |
| Gail M. Farfel | Director | Buy | $22K | 2022-05-16 |
| Gail M. Farfel | Director | Buy | $8K | 2022-05-11 |
| Gail M. Farfel | Director | Buy | $959 | 2022-05-10 |
| Gail M. Farfel | Director | Buy | $9K | 2022-05-09 |
| Judith J. Robertson | Director | Buy | $118K | 2022-03-14 |
| Norman Sussman | Chief Medical Officer | Sell | $10K | 2021-12-10 |